NON-ALCOHOLIC FATTY LIVER DISEASE
Clinical trials for NON-ALCOHOLIC FATTY LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new NON-ALCOHOLIC FATTY LIVER DISEASE trials appear
Sign up with your email to follow new studies for NON-ALCOHOLIC FATTY LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Diabetes pill trial aims to shrink Kids' fatty livers
Disease control Not yet recruitingThis study is testing if a diabetes medication called empagliflozin can safely reduce fat in the liver of teenagers with obesity-related fatty liver disease (NAFLD). Forty adolescents will take the pill or a placebo daily for six months while also receiving lifestyle counseling. …
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: PHASE2 • Sponsor: Justin Ryder • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
AI steps in to catch a silent liver threat missed in ER scans
Diagnosis Not yet recruitingThis study tests a new computer tool designed to catch a common but often overlooked finding on emergency room scans: fatty liver disease. The AI system alerts doctors to the finding, provides a risk assessment for the patient, and suggests appropriate follow-up steps. The goal i…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: NA • Sponsor: Northwestern University • Aim: Diagnosis
Last updated Mar 30, 2026 14:32 UTC
-
First human tests begin for new fatty liver disease drug
Knowledge-focused Not yet recruitingThis is an early-stage study to test the safety of a new drug called XTYW007 in healthy volunteers and people with high 'bad' cholesterol (LDL-C). Researchers will give single and multiple doses to see how the body handles the drug, check for side effects, and see if food changes…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: EARLY_PHASE1 • Sponsor: Xi'an Xintong Pharmaceutical Research Co.,Ltd. • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:43 UTC
-
Early trial tests if lowering insulin can shrink fatty liver
Knowledge-focused Not yet recruitingThis early-stage study aims to understand if lowering high insulin levels for one week can reduce the liver's production of new fat, a key driver of fatty liver disease. Researchers will compare a drug called diazoxide against a placebo in 25 adults with obesity, insulin resistan…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: PHASE1 • Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC
-
Scientists test if lowering insulin can fight fatty liver disease
Knowledge-focused Not yet recruitingThis study aims to understand how high insulin levels contribute to fatty liver disease in people who are overweight and insulin resistant. Researchers will temporarily control insulin levels in 36 participants to measure how the liver produces fat and sugar. The goal is to gathe…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: PHASE1 • Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC